Animax

Verify with FDA CVM →

63 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
63
Total Reports
4
Deaths Reported
630.0%
Death Rate

Active Ingredients

Animax

Administration Routes

TopicalUnknownAuricular (Otic)

Species Affected

Dog 33
Cat 30

Most Affected Breeds

Domestic Shorthair 19
Retriever - Labrador 5
Terrier - Bull - American Pit 4
Retriever - Golden 4
Spaniel (unspecified) 3
Domestic Longhair 3
Domestic Mediumhair 2
Terrier (unspecified) 2
Shepherd Dog - German 2
Pug 2

Most Reported Reactions

Diarrhoea 7
Lethargy (see also Central nervous system depression in Neurological) 7
Lack of efficacy - NOS 7
Pruritus 6
Behavioural disorder NOS 5
Not eating 5
Vomiting 5
Abnormal cytology 5
Crust 5
Lethargy (see also Central nervous system depression in 'Neurological') 4
Vocalisation 4
Skin scab 4

Outcome Breakdown

Ongoing
42 (66.7%)
Recovered/Normal
11 (17.5%)
Outcome Unknown
6 (9.5%)
Died
2 (3.2%)
Euthanized
2 (3.2%)

Data Summary

Metric Value
Total adverse event reports 63
Reports involving death 4
Case-fatality rate (reported events) 630.0%
Distinct species in reports 2
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Animax Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 63 adverse event reports referencing Animax, including 4 reports in which the animal died — a 630.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Animax. Reported administration routes include Topical, Unknown, Auricular (Otic). These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Animax reports are Dog (33 reports), Cat (30 reports), with Dog accounting for the largest share. Within those species, Domestic Shorthair (19), Retriever - Labrador (5), Terrier - Bull - American Pit (4) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Animax are Diarrhoea (7), Lethargy (see also Central nervous system depression in Neurological) (7), Lack of efficacy - NOS (7), Pruritus (6). Of the 63 reports with a coded outcome, Ongoing is the leading category at 66.7%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Animax.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial